Hansa Biopharma has treated the first commercial Australian living donor [...]
Aravax’s PVX108 has received FDA Fast Track designation as the [...]
CAMP4 Therapeutics has received Australian regulatory and ethics clearance to [...]
A Phase 1/1b clinical trial has begun in Australia to [...]